Physician profile
James Scott
NPI 1831334960
$5,267.90
in general payments reported to CMS, 2019-2025
16 companies · $558 in 2025
The $558 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $73.55 · 2021: $330 · 2022: $786 · 2023: $249 · 2024: $3,044 · 2025: $558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,310 · Food and Beverage: $1,542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,309.79 |
| Food and Beverage | $1,541.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,389.54 | 2021-2025 | Mako, Insignia, Triathlon |
| Smith+Nephew, INC. | $1,758.71 | 2019-2024 | Real Intelligence, Polarstem, Legion |
| Zimmer Biomet Holdings, INC. | $415.47 | 2022 | |
| Depuy Synthes Sales INC. | $255.67 | 2023-2025 | Na, Tfn-Advance, Monovisc |
| Pacira Pharmaceuticals Incorporated | $125.13 | 2024 | Iovera |
| Heraeus Medical, LLC. | $110.64 | 2023-2025 | Palacos |
| Ferring Pharmaceuticals INC. | $43.63 | 2022-2023 | Euflexxa |
| Medacta USA, INC. | $34.17 | 2021-2022 | |
| Heron Therapeutics, INC. | $30.51 | 2023-2024 | Zynrelef |
| Solventum Corporation | $20.03 | 2025 | Prevena |
| International Rehabilitative Sciences, INC | $17.60 | 2024 | Rs 4i Plus Sequential Stimulator |
| Collegium Pharmaceutical, INC. | $17.06 | 2023 | Xtampza |
| Molnlycke Health Care US, LLC | $14.14 | 2024 | Avance |
| Kci USA, INC. | $13.77 | 2023 | V.A.C. Veraflo Cleanse Choice, Prevena, V.A.C. Dermatac |
| Kowa Pharmaceuticals America, INC. | $12.99 | 2023 | Seglentis |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $8.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.